ERG and prostate cancer: It had earlier been reported that the ERG gene was the most commonly overexpressed proto-oncogene in prostate cancer (present in about 72% of cases of prostate cancer) (Petrovics et al, 2005), and Tomlins et al now proposed a mechanism to explain the overexpression.